NL8901433A - Carboplatinpreparaat. - Google Patents

Carboplatinpreparaat. Download PDF

Info

Publication number: NL8901433A
Authority: NL; Netherlands
Prior art keywords: carboplatin; preparation; solution; buffered; concentration
Prior art date: 1989-06-06

Application number

NL8901433A

Other languages

English (en)

Dutch (nl)

Original Assignee

Pharmachemie Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-06-06

Filing date

1989-06-06

Publication date

1991-01-02

1989-06-06 Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv

1989-06-06 Priority to NL8901433A priority Critical patent/NL8901433A/nl

1990-05-28 Priority to DE90201354T priority patent/DE69002697T2/de

1990-05-28 Priority to EP90201354A priority patent/EP0401896B1/fr

1990-05-28 Priority to DK90201354.9T priority patent/DK0401896T3/da

1990-05-28 Priority to AT90201354T priority patent/ATE92759T1/de

1990-05-28 Priority to ES90201354T priority patent/ES2044405T3/es

1990-05-29 Priority to US07/529,917 priority patent/US5104896A/en

1990-05-31 Priority to FI902713A priority patent/FI96276C/fi

1990-06-04 Priority to CA002018229A priority patent/CA2018229C/fr

1990-06-05 Priority to AU56296/90A priority patent/AU630961B2/en

1990-06-05 Priority to NO902488A priority patent/NO301048B1/no

1990-06-06 Priority to IL9465290A priority patent/IL94652A/en

1990-06-06 Priority to JP2146385A priority patent/JP2825934B2/ja

1991-01-02 Publication of NL8901433A publication Critical patent/NL8901433A/nl

Links

238000002360 preparation method Methods 0.000 title claims description 11
190000008236 carboplatin Chemical compound 0.000 claims abstract description 27
229960004562 carboplatin Drugs 0.000 claims abstract description 27
239000000872 buffer Substances 0.000 claims description 5
239000006172 buffering agent Substances 0.000 claims description 3
239000008363 phosphate buffer Substances 0.000 claims description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
239000000243 solution Substances 0.000 abstract description 10
239000007864 aqueous solution Substances 0.000 abstract description 2
239000000203 mixture Substances 0.000 abstract description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 14
229910000147 aluminium phosphate Inorganic materials 0.000 description 7
229910000403 monosodium phosphate Inorganic materials 0.000 description 4
235000019799 monosodium phosphate Nutrition 0.000 description 4
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 4
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 3
239000007983 Tris buffer Substances 0.000 description 1
239000008366 buffered solution Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000000824 cytostatic agent Substances 0.000 description 1
230000001085 cytostatic effect Effects 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
HRGDZIGMBDGFTC-UHFFFAOYSA-N platinum(2+) Chemical compound [Pt+2] HRGDZIGMBDGFTC-UHFFFAOYSA-N 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
231100000167 toxic agent Toxicity 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Powder Metallurgy (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NL8901433A 1989-06-06 1989-06-06 Carboplatinpreparaat. NL8901433A (nl)

Priority Applications (13)

Application Number	Priority Date	Filing Date	Title
NL8901433A NL8901433A (nl)	1989-06-06	1989-06-06	Carboplatinpreparaat.
DE90201354T DE69002697T2 (de)	1989-06-06	1990-05-28	Carboplatinzusammensetzung.
EP90201354A EP0401896B1 (fr)	1989-06-06	1990-05-28	Composition de carboplatine
DK90201354.9T DK0401896T3 (da)	1989-06-06	1990-05-28	Carboplatinmateriale
AT90201354T ATE92759T1 (de)	1989-06-06	1990-05-28	Carboplatinzusammensetzung.
ES90201354T ES2044405T3 (es)	1989-06-06	1990-05-28	Un procedimiento para preparar una composicion de carboplatino.
US07/529,917 US5104896A (en)	1989-06-06	1990-05-29	Carboplatin composition
FI902713A FI96276C (fi)	1989-06-06	1990-05-31	Menetelmä stabiilin karboplatiinivesiliuoksen valmistamiseksi
CA002018229A CA2018229C (fr)	1989-06-06	1990-06-04	Composition de carboplatine
AU56296/90A AU630961B2 (en)	1989-06-06	1990-06-05	Carboplatin composition
NO902488A NO301048B1 (no)	1989-06-06	1990-06-05	Fremgangsmåte ved fremstilling av et karboplatinpreparat
IL9465290A IL94652A (en)	1989-06-06	1990-06-06	Carboplatin preparation
JP2146385A JP2825934B2 (ja)	1989-06-06	1990-06-06	カルボプラチン組成物

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NL8901433A NL8901433A (nl)	1989-06-06	1989-06-06	Carboplatinpreparaat.
NL8901433		1989-06-06

Publications (1)

Publication Number	Publication Date
NL8901433A true NL8901433A (nl)	1991-01-02

Family

ID=19854785

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8901433A NL8901433A (nl)	1989-06-06	1989-06-06	Carboplatinpreparaat.

Country Status (13)

Country	Link
US (1)	US5104896A (fr)
EP (1)	EP0401896B1 (fr)
JP (1)	JP2825934B2 (fr)
AT (1)	ATE92759T1 (fr)
AU (1)	AU630961B2 (fr)
CA (1)	CA2018229C (fr)
DE (1)	DE69002697T2 (fr)
DK (1)	DK0401896T3 (fr)
ES (1)	ES2044405T3 (fr)
FI (1)	FI96276C (fr)
IL (1)	IL94652A (fr)
NL (1)	NL8901433A (fr)
NO (1)	NO301048B1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5124317A (en) *	1985-08-02	1992-06-23	Farmitalia Carlo Erba S.P.A.	Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en)	1985-08-02	1999-11-02	Pharmacia & Upjohn Company	Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5455270A (en) *	1993-08-11	1995-10-03	Bristol-Myers Squibb Co.	Stabilized solutions of platinum(II) antitumor agents
AU5878294A (en) *	1994-02-07	1995-08-21	Kiss Laboratories S.R.O.	Anti-tumour medical preparation on the basis of carboplatin and the method of its production
JP3547755B2 (ja) *	1994-08-08	2004-07-28	デビオファーム・エス・アー	オキサリプラティヌムの医薬的に安定な製剤
CZ292170B6 (cs) *	1998-08-14	2003-08-13	Pliva-Lachema A.S.	Farmaceutická kompozice s protinádorovým účinkem na bázi carboplatiny
US7048282B2 (en) *	2000-01-24	2006-05-23	Bernstein Beteiligungs Gmbh	Sports device, preferably a snow or water vehicle
AUPQ641100A0 (en) *	2000-03-23	2000-04-15	Australia Nuclear Science & Technology Organisation	Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
EP1404689A1 (fr) *	2001-07-02	2004-04-07	Debiopharm S.A.	Substance active a base d'oxaliplatine presentant une faible teneur en acide oxalique
AU2005329764B2 (en) *	2005-03-28	2010-08-12	Dabur Pharma Ltd.	Stable pharmaceutical compositions of platinum (II) antitumour agents
US20090130017A1 (en) *	2007-11-19	2009-05-21	Searete Llc	Targeted short-lived drug delivery
KR101127159B1 (ko) *	2009-11-02	2012-03-20	한국생명공학연구원	식물병원성 그람음성 세균의 분비체계를 저해하는 카보프라틴 화합물을 유효성분으로 함유하는 식물병 방제제
KR101055409B1 (ko) *	2010-12-31	2011-08-08	내쇼날씨엔디 주식회사	튜브형 썰매
CA3028566C (fr)	2015-02-27	2023-01-03	Canon Kabushiki Kaisha	Unite tambour, cartouche et element d'accouplement
US12427104B1 (en)	2025-04-01	2025-09-30	Ingenus Pharmaceuticals, Llc	Injectable carboplatin formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4339437A (en) *	1976-12-27	1982-07-13	Research Corporation	Anti-tumor method
US4873226A (en) *	1983-06-17	1989-10-10	Delta Metals, Inc.	Method of inhibiting herpetic lesions by the use of platinum coordination compounds
NL8303657A (nl) *	1983-10-24	1985-05-17	Pharmachemie Bv	Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
GB8416048D0 (en) *	1984-06-22	1984-07-25	Johnson Matthey Plc	Anti-tumour compounds of platinum
CS269719B1 (en) *	1986-12-29	1990-05-14	Kiss Frantisek	Platinum cytostatic

1989
- 1989-06-06 NL NL8901433A patent/NL8901433A/nl not_active Application Discontinuation
1990
- 1990-05-28 DK DK90201354.9T patent/DK0401896T3/da active
- 1990-05-28 AT AT90201354T patent/ATE92759T1/de not_active IP Right Cessation
- 1990-05-28 EP EP90201354A patent/EP0401896B1/fr not_active Expired - Lifetime
- 1990-05-28 DE DE90201354T patent/DE69002697T2/de not_active Expired - Fee Related
- 1990-05-28 ES ES90201354T patent/ES2044405T3/es not_active Expired - Lifetime
- 1990-05-29 US US07/529,917 patent/US5104896A/en not_active Expired - Lifetime
- 1990-05-31 FI FI902713A patent/FI96276C/fi not_active IP Right Cessation
- 1990-06-04 CA CA002018229A patent/CA2018229C/fr not_active Expired - Fee Related
- 1990-06-05 NO NO902488A patent/NO301048B1/no not_active IP Right Cessation
- 1990-06-05 AU AU56296/90A patent/AU630961B2/en not_active Ceased
- 1990-06-06 IL IL9465290A patent/IL94652A/en not_active IP Right Cessation
- 1990-06-06 JP JP2146385A patent/JP2825934B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69002697T2 (de)	1994-02-10
DE69002697D1 (de)	1993-09-16
NO301048B1 (no)	1997-09-08
EP0401896B1 (fr)	1993-08-11
JPH0356420A (ja)	1991-03-12
JP2825934B2 (ja)	1998-11-18
AU630961B2 (en)	1992-11-12
ES2044405T3 (es)	1994-01-01
FI96276C (fi)	1996-06-10
IL94652A (en)	1994-02-27
CA2018229C (fr)	1998-04-07
IL94652A0 (en)	1991-04-15
US5104896A (en)	1992-04-14
DK0401896T3 (da)	1993-11-15
AU5629690A (en)	1990-12-13
FI902713A0 (fi)	1990-05-31
ATE92759T1 (de)	1993-08-15
NO902488L (no)	1990-12-07
NO902488D0 (no)	1990-06-05
EP0401896A1 (fr)	1990-12-12
CA2018229A1 (fr)	1990-12-06
FI96276B (fi)	1996-02-29

Legal Events

Date	Code	Title	Description
1991-01-02	A1B	A search report has been drawn up
1992-02-03	BV	The patent application has lapsed

Publication	Publication Date	Title
Packham et al.	1967	Alteration of the response of platelets to surface stimuli by pyrazole compounds
DE69311278T2 (de)	1997-10-30	Stabile pharmazeutische Zubereitung mit Fumagillolderivaten
NL8901432A (nl)	1991-01-02	Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan.
Opperdoes et al.	1976	Trypanosoma brucei: an evaluation of salicylhydroxamic acid as a trypanocidal drug
SU1514240A3 (ru)	1989-10-07	СПОСОБ ПОЛУЧЕНИЯ СТАБИЛЬНЫХ ЦИКЛОДЕКСТРИН-РОМАШКОВЫХ КОМПЛЕКСОВ, включения
US4637834A (en)	1987-01-20	Aqueous protein solutions which are stable towards denaturing, processes for their preparation and their use
NL8300440A (nl)	1983-09-01	Gestabiliseerde insuline-oplossingen en werkwijze ter bereiding ervan.
KR950703988A (ko)	1995-11-17	긴 보장기간을 갖는 g-csf의 수성 약제 조성물(aqueous pharmaceutical preparations of g-csf whth a long shelf life)
RS50360B (sr)	2009-11-10	Farmaceutske formulacije derivata platine
EP2089060A1 (fr)	2009-08-19	Préparation liquide comprenant un complexe de pimobendane et de cyclodextrine
PT819010E (pt)	2004-01-30	Formulacao de proteina compreendendo factor viii ou factor ix de coagulacao numa solucao aquosa
EP0401896B1 (fr)	1993-08-11	Composition de carboplatine
Bauer et al.	2017	Methyl fumarate‐derived iron carbonyl complexes (FumET‐CORMs) as powerful anti‐inflammatory agents
US2411897A (en)	1946-12-03	Pharmaceutical solution
FR2863891A1 (fr)	2005-06-24	Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
Sri‐Pathmanathan et al.	1994	Clofazimine alters the energy metabolism and inhibits the growth rate of a human lung‐cancer cell line in vitro and in vivo
EP2908829A1 (fr)	2015-08-26	Complexe d'anthocyanidine pour le traitement du myélome multiple
JPH06511006A (ja)	1994-12-08	溶血予防
JPH05505813A (ja)	1993-08-26	４―［２―（ベンゼンスルホニルアミノ）―エチル］―フェノキシ酢酸の医薬用水溶液
KR20240121186A (ko)	2024-08-08	주사용 조성물, 이를 포함하는 약학적 제제 및 이의 제조 방법
RU2281957C1 (ru)	2006-08-20	Водорастворимый натрий-, кальций-, железополигалактуронат, стимулирующий процесс кроветворения
Fiszer-Szafarz et al.	1970	Hyaluronic acid content of the interstitial fluid of Walker carcinoma 256
NL9002412A (nl)	1991-06-03	Injecteerbare oplossing en werkwijze voor de bereiding daarvan.
Hertz et al.	1964	Studies on vitamin B12 retention comparison of retention following intramuscular injection of cyanocobalamin and hydroxocobalamin
US3219532A (en)	1965-11-23	Preparations having a protracted b12 effect and method of preparing same